Nicotinic Acetylcholine Receptors in Health and Disease

Nicotinic acetylcholine receptors (nAChRs) are important potential translational targets for the treatment of diseases such as Alzheimer's, Parkinson's, and schizophrenia, as well as addiction. This book focuses on their roles and function inside and outside the nervous system, with an emphasis on translational implications and future prospects.

Format: Paperback / softback
Length: 350 pages
Publication date: 01 March 2023
Publisher: Elsevier Science Publishing Co Inc

Nicotinic acetylcholine receptors (nAChRs) are crucial in the development of numerous diseases, including Alzheimer's, Parkinson's, and schizophrenia. They also play a significant role in addiction therapy. This comprehensive book delves into the roles and functions of nAChRs within and outside the nervous system, with a particular focus on their translational implications and potential for treating various disorders. By gaining a deeper understanding of the basic neurobiology and clinical applications of nAChRs, researchers and healthcare professionals can develop innovative treatments for a wide range of major illnesses.

The nAChRs are a class of receptors that are involved in the transmission of nerve impulses in the brain. They are located on the postsynaptic membrane of neurons and are responsible for the activation of neurotransmitter release. There are five different types of nAChRs, each with its own unique properties and functions.

One of the most well-known roles of nAChRs is their involvement in the development and progression of Alzheimer's disease. Studies have shown that the levels of nAChRs in the brain decrease as the disease progresses, leading to cognitive decline and memory loss. Additionally, nAChRs have been implicated in the development of Parkinson's disease, where they are believed to play a role in the regulation of motor function.

In addition to their roles in neurological disorders, nAChRs are also important in the treatment of addiction. Nicotine, the addictive substance in tobacco, binds to nAChRs, leading to the activation of dopamine release in the brain. This activation is what creates the pleasurable effects of nicotine addiction, and it is also what makes it difficult for smokers to quit.

Researchers have been exploring the use of nAChRs as potential therapeutic targets for addiction. One approach is to develop drugs that mimic the effects of nicotine, but without the addictive properties. Another approach is to use gene therapy to modify the expression of nAChRs, reducing the levels of dopamine release and reducing the cravings for nicotine.

Despite the potential benefits of nAChRs as therapeutic targets, there are also challenges associated with their use. One of the biggest challenges is the development of safe and effective drugs that target nAChRs. Additionally, there is still a need for more research to better understand the roles and functions of nAChRs in different diseases and to develop more targeted therapies.

In conclusion, Nicotinic acetylcholine receptors (nAChRs) are important in the development of numerous diseases, including Alzheimer's, Parkinson's, and schizophrenia. They also play a significant role in addiction therapy. This comprehensive book provides valuable insights into the roles and functions of nAChRs within and outside the nervous system, with a particular focus on their translational implications and potential for treating various disorders. By gaining a deeper understanding of the basic neurobiology and clinical applications of nAChRs, researchers and healthcare professionals can develop innovative treatments for a wide range of major illnesses.

Dimension: 229 x 152 (mm)
ISBN-13: 9780128199589